Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics
Kapil Gadkar(Sea Turtle Conservancy), Justin M. Scheer(Genentech), Whitney Shatz-Binder, Makia Nakamura, Chingwei V. Lee, Y. Gloria Meng, Germaine Fuh, Phil Hass, Hok Seon Kim(Kaiser Permanente South San Francisco Medical Center), Christoph Spiess(Genentech), J. Michael Elliott, Jennifer E. Le Couter(Molecular Oncology (United States)), Sarah Sanowar, Jianhua Zhang(Tianjin University), Cinthia V. Pastuskovas, T. Noelle Lombana
Cited by 68
Related Papers
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
|Proceedings of the National Academy of Sciences|2010|666
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
|Science Translational Medicine|2014|373
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
|Science Translational Medicine|2013|267